Applied Biosciences Hires Former Pfizer Business Unit Chief Medical Officer as Chief Executive Officer

LOS ANGELES, May 07, 2019 (GLOBE NEWSWIRE) — Applied BioSciences Corp. (OTCQB: APPB), a diversified cannabinoid-based therapeutics company focused on

Read more

Applied BioSciences Retains the Emmes Group to Partner on Therapeutic Development Initiatives

LOS ANGELES, CA / ACCESSWIRE / April 8, 2019 / Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused

Read more

Applied BioSciences Announces Partnership with Boxing Heavyweight Champion Shannon Briggs

LOS ANGELES, March 20, 2019 (GLOBE NEWSWIRE) — Applied Biosciences Corp. (OTCQB: APPB), a diversified cannabinoid therapeutics company focused on

Read more

Relevium Launches the Push and Pull System™, Targeting a New Revenue Stream in the Burgeoning Cosmeceutical Market

MONTREAL, Feb. 07, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”,  OTC: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce the

Read more